Peter Hinderlie
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 23
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 7
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 4
- Oncology 13
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Martin Felices (22 shared papers)Jeffrey S. Miller (22 shared papers)Melissa A. Geller (7 shared papers)Laura E. Bendzick (9 shared papers)Daniel A. Vallera (11 shared papers)Bruce R. Blazar (5 shared papers)Behiye Kodal (9 shared papers)Alexander J. Lenvik (3 shared papers)
- Journals
- Blood Advances (4 papers)Annals of Oncology (2 papers)Cancers (2 papers)Cancer Immunology Research (2 papers)JCI Insight (2 papers)
- Partner nations
- United StatesSwedenNetherlands
In The Last Decade
Peter Hinderlie
23 papers receiving 867 citations
Peers
Comparison fields: 5 of 54
- Immunology 769
- Oncology 531
- Hematology 90
- Virology 17
- Radiology, Nuclear Medicine and Imaging 74
Countries citing papers authored by Peter Hinderlie
This map shows the geographic impact of Peter Hinderlie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hinderlie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hinderlie more than expected).
Fields of papers citing papers by Peter Hinderlie
This network shows the impact of papers produced by Peter Hinderlie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hinderlie. The network helps show where Peter Hinderlie may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hinderlie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 184 | |
| 2 | 2018 | 95 | |
| 3 | 2018 | 95 | |
| 4 | 2019 | 82 | |
| 5 | 2020 | 71 | |
| 6 | 2019 | 70 | |
| 7 | 2020 | 51 | |
| 8 | 2018 | 47 | |
| 9 | 2021 | 37 | |
| 10 | 2022 | 30 | |
| 11 | 2021 | 26 | |
| 12 | 2018 | 25 | |
| 13 | 2023 | 14 | |
| 14 | 2022 | 14 | |
| 15 | 2023 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2024 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2019 | 4 | |
| 20 | 2021 | 4 |
About Peter Hinderlie
Peter Hinderlie is a scholar working on Immunology, Oncology, Hematology, Epidemiology and Molecular Biology, having authored 23 papers that have together received 878 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (23 papers), CAR-T cell therapy research (10 papers), T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers), Immune cells in cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cytomegalovirus and herpesvirus research (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Immunology (769 citations), Oncology (531 citations), Hematology (90 citations), Virology (17 citations) and Radiology, Nuclear Medicine and Imaging (74 citations). Peter Hinderlie has collaborated with scholars based in United States, Sweden and Netherlands. Frequent co-authors include Martin Felices, Jeffrey S. Miller, Melissa A. Geller, Laura E. Bendzick, Daniel A. Vallera, Bruce R. Blazar, Behiye Kodal, Alexander J. Lenvik, Ron McElmurry and Sarah Cooley. Their work appears in journals such as Blood Advances, Annals of Oncology, Cancers, Cancer Immunology Research and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.